Dr. Reidy Lagunes on the Potential of Immunotherapy in NETs

Dr. Lagunes on Potential Combinations in the Treatment of Patients With NETsПодробнее

08. NET Treatments: Medical Therapies & Clinical Trials (Dr. Diane Reidy) - 2022 LACNETS ConferenceПодробнее

Dr. Reidy-Lagunes on Sequencing Therapies for Patients With NETsПодробнее

Dr Reidy-Lagunes on the Evolving NET Treatment ParadigmПодробнее

Luncheon with the Experts: Diane Reidy-Lagunes, MDПодробнее

Luncheon with the Experts: Diane Reidy-Lagunes, MDПодробнее

LACNETS Webinar: Focus on Immunotherapy & High-Grade NETs with Dr. Neena VijayvergiaПодробнее

Immunotherapy of NETsПодробнее

Dr. Lagunes on the Importance of Developing More Personalized Treatments in NETsПодробнее

Dr. Reidy-Lagunes on Determining the Site of Unknown Primary in Metastatic NETsПодробнее

CURRENT LANDSCAPE OF NET CLINICAL TRIALS ANDFUTURE DIRECTION Diane Reidy Lagunes, MD, Memorial SloaПодробнее

LIVE with Dr. Diane Reidy-Lagunes!Подробнее

Dr. Reidy-Lagunes on FDA Approval of Telotristat Epitrate for Carcinoid SyndromeПодробнее

The Potential for Combination Therapy in Neuroendocrine TumorsПодробнее

pNETs: Therapeutic OptionsПодробнее

Emerging Therapies for pNETsПодробнее

(5) "Immunotherapy" with Dr. David Metz - - LACNETS CFCF 2015 NET ConferenceПодробнее

Top 7 Immunotherapy Clinical Trial Questions Answered | Carte Blanche | M-NetПодробнее

Challenges in Sequencing and Combination Therapy in pNETsПодробнее